Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1852 | 6090 | 38.5 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
422 | 3 | C REACTIVE PROTEIN//STAT3//HAPTOGLOBIN | 28303 |
1852 | 2 | INTERLEUKIN 1//INTERLEUKIN 1 RECEPTOR ANTAGONIST//POLYMORPHISM | 6090 |
1835 | 1 | INTERLEUKIN 1//INTERLEUKIN 1 RECEPTOR ANTAGONIST//LYMPHOKINE RESEARCH | 2468 |
10285 | 1 | IL1RN//INTERLEUKIN 1 BETA GENE//INTERLEUKIN 1B | 1076 |
12217 | 1 | LYMPHOTOXIN ALPHA//GALECTIN 2//TNF MICROSATELLITE | 923 |
17299 | 1 | 174G C//INTERLEUKIN 6//INTERLEUKIN 6 POLYMORPHISM | 607 |
20921 | 1 | BASAL CELL CARCINOMA CELLS//NIJMEGEN MOL LIFE SCI 278//SILTUXIMAB | 441 |
21741 | 1 | VA NEGOVSKY GEN REANIMATOL//ANESTHESIOL CRIT CARE MED TEACHING//FUNCTIONAL GENETIC POLYMORPHISM | 407 |
30473 | 1 | RS3783553//MICROENCAPSULATED CELLS//ABORAT INNOVAT HEMATOLMINIST HLTHAFFILI | 168 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INTERLEUKIN 1 | authKW | 101042 | 4% | 7% | 271 |
2 | INTERLEUKIN 1 RECEPTOR ANTAGONIST | authKW | 100411 | 2% | 18% | 112 |
3 | POLYMORPHISM | authKW | 84779 | 12% | 2% | 743 |
4 | LYMPHOTOXIN ALPHA | authKW | 64911 | 1% | 36% | 36 |
5 | IL1RN | authKW | 61056 | 0% | 42% | 29 |
6 | INTERLEUKIN 6 | authKW | 58496 | 5% | 4% | 309 |
7 | IL 1 RECEPTOR ANTAGONIST | authKW | 55701 | 1% | 25% | 44 |
8 | CYTOKINE | journal | 36546 | 3% | 4% | 180 |
9 | LYMPHOKINE RESEARCH | journal | 36494 | 1% | 16% | 46 |
10 | 174G C | authKW | 35085 | 0% | 100% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 22991 | 30% | 0% | 1840 |
2 | Rheumatology | 5743 | 6% | 0% | 356 |
3 | Oncology | 3830 | 15% | 0% | 898 |
4 | Cell Biology | 2403 | 12% | 0% | 729 |
5 | Medicine, Research & Experimental | 1583 | 7% | 0% | 434 |
6 | Biochemistry & Molecular Biology | 1528 | 17% | 0% | 1052 |
7 | Genetics & Heredity | 1508 | 8% | 0% | 481 |
8 | Critical Care Medicine | 725 | 2% | 0% | 151 |
9 | Hematology | 546 | 4% | 0% | 226 |
10 | Pathology | 378 | 3% | 0% | 179 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VA NEGOVSKY GEN REANIMATOL | 20044 | 0% | 67% | 6 |
2 | RHEUMATOL B115 | 17897 | 0% | 71% | 5 |
3 | MED GENET PATHOL ONCOL | 15036 | 0% | 100% | 3 |
4 | KLIN FOR ERGRP OCK MULTIORGANVERSAGEN | 13918 | 0% | 56% | 5 |
5 | INVEST REUMATOL SISTEMA MUSCULO ESQUELET | 10396 | 0% | 23% | 9 |
6 | ANESTHESIOL CRIT CARE MED TEACHING | 10024 | 0% | 100% | 2 |
7 | BIOL RHEUMATOID ARTHRIT GENET GENOM STUDY SYNDI | 10024 | 0% | 100% | 2 |
8 | DNASHEF TECHNOL | 10024 | 0% | 100% | 2 |
9 | MOL VIROL VIROL SERV | 10024 | 0% | 100% | 2 |
10 | NIJMEGEN MOL LIFE SCI 278 | 10024 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CYTOKINE | 36546 | 3% | 4% | 180 |
2 | LYMPHOKINE RESEARCH | 36494 | 1% | 16% | 46 |
3 | EUROPEAN CYTOKINE NETWORK | 15320 | 1% | 6% | 55 |
4 | JOURNAL OF IMMUNOLOGY | 9168 | 5% | 1% | 320 |
5 | GENES AND IMMUNITY | 8520 | 1% | 4% | 49 |
6 | LYMPHOKINE AND CYTOKINE RESEARCH | 6132 | 0% | 7% | 17 |
7 | INTERNATIONAL JOURNAL OF IMMUNOGENETICS | 5716 | 1% | 4% | 31 |
8 | HUMAN IMMUNOLOGY | 5490 | 1% | 2% | 72 |
9 | EUROPEAN JOURNAL OF IMMUNOGENETICS | 3529 | 0% | 4% | 20 |
10 | BIOTHERAPY | 2856 | 0% | 4% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERLEUKIN 1 | 101042 | 4% | 7% | 271 | Search INTERLEUKIN+1 | Search INTERLEUKIN+1 |
2 | INTERLEUKIN 1 RECEPTOR ANTAGONIST | 100411 | 2% | 18% | 112 | Search INTERLEUKIN+1+RECEPTOR+ANTAGONIST | Search INTERLEUKIN+1+RECEPTOR+ANTAGONIST |
3 | POLYMORPHISM | 84779 | 12% | 2% | 743 | Search POLYMORPHISM | Search POLYMORPHISM |
4 | LYMPHOTOXIN ALPHA | 64911 | 1% | 36% | 36 | Search LYMPHOTOXIN+ALPHA | Search LYMPHOTOXIN+ALPHA |
5 | IL1RN | 61056 | 0% | 42% | 29 | Search IL1RN | Search IL1RN |
6 | INTERLEUKIN 6 | 58496 | 5% | 4% | 309 | Search INTERLEUKIN+6 | Search INTERLEUKIN+6 |
7 | IL 1 RECEPTOR ANTAGONIST | 55701 | 1% | 25% | 44 | Search IL+1+RECEPTOR+ANTAGONIST | Search IL+1+RECEPTOR+ANTAGONIST |
8 | 174G C | 35085 | 0% | 100% | 7 | Search 174G+C | Search 174G+C |
9 | GENE POLYMORPHISM | 32891 | 2% | 5% | 133 | Search GENE+POLYMORPHISM | Search GENE+POLYMORPHISM |
10 | IL 1 | 32165 | 1% | 7% | 89 | Search IL+1 | Search IL+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DINARELLO, CA , (1996) BIOLOGIC BASIS FOR INTERLEUKIN-1 IN DISEASE.BLOOD. VOL. 87. ISSUE 6. P. 2095 -2147 | 219 | 44% | 2889 |
2 | DINARELLO, CA , (1991) INTERLEUKIN-1 AND INTERLEUKIN-1 ANTAGONISM.BLOOD. VOL. 77. ISSUE 8. P. 1627 -1652 | 157 | 59% | 2193 |
3 | XU, JL , YIN, ZQ , CAO, SY , GAO, W , LIU, LX , YIN, YM , LIU, P , SHU, YQ , (2013) SYSTEMATIC REVIEW AND META-ANALYSIS ON THE ASSOCIATION BETWEEN IL-1B POLYMORPHISMS AND CANCER RISK.PLOS ONE. VOL. 8. ISSUE 5. P. - | 92 | 77% | 16 |
4 | AREND, WP , (1993) INTERLEUKIN-1 RECEPTOR ANTAGONIST.ADVANCES IN IMMUNOLOGY, VOL 54. VOL. 54. ISSUE . P. 167-227 | 119 | 65% | 428 |
5 | AREND, WP , MALYAK, M , GUTHRIDGE, CJ , GABAY, C , (1998) INTERLEUKIN-1 RECEPTOR ANTAGONIST: ROLE IN BIOLOGY.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 16. ISSUE . P. 27 -55 | 94 | 59% | 580 |
6 | LENNARD, AC , (1995) INTERLEUKIN-1 RECEPTOR ANTAGONIST.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 15. ISSUE 1. P. 77-105 | 116 | 72% | 81 |
7 | ROUX-LOMBARD, P , (1998) THE INTERLEUKIN-1 FAMILY.EUROPEAN CYTOKINE NETWORK. VOL. 9. ISSUE 4. P. 565 -576 | 105 | 69% | 56 |
8 | DINARELLO, CA , (1989) INTERLEUKIN-1 AND ITS BIOLOGICALLY RELATED CYTOKINES.ADVANCES IN IMMUNOLOGY. VOL. 44. ISSUE . P. 153-205 | 99 | 47% | 1133 |
9 | DINARELLO, CA , (1994) THE INTERLEUKIN-1 FAMILY - 10 YEARS OF DISCOVERY.FASEB JOURNAL. VOL. 8. ISSUE 15. P. 1314-1325 | 73 | 67% | 594 |
10 | PATARCA, R , FLETCHER, MA , (1997) INTERLEUKIN-1: BASIC SCIENCE AND CLINICAL APPLICATIONS.CRITICAL REVIEWS IN ONCOGENESIS. VOL. 8. ISSUE 2-3. P. 143 -188 | 184 | 41% | 8 |
Classes with closest relation at Level 2 |